Epstein Secrets

n: MR047987t. Requisition: 0006029 Collected: 08/14/2018 Received: 08/1412018 /21:21 EDT Reported: 08/192018 / 13:55 EDT Client N: 56W5265 MOSKOWITZ, BRUCL W IIRUCE MOSKOWITZ, MD Attn: NATIONWIDE ACCOUNT 1411 N FLAGLER DR STE 7100 WEST PALM BEACIL FL 33401.3418 Test Name PTH, INTACT AND CALC

006030 Collected: 08/14/2018 Received: 08115/2018 / 15:11 EDT Reported: 08/16/2018 107.59 EDT Client a: 78300020 56W5265 MOSKOWITZ, BRUCE W BRUCE MOSKOWITZ, MD Atm: NATIONWIDE ACCOUNT 1411 N PLAGLER DR STE 7100 WEST PALM BEACH. EL 33401-3418 Test Name LIPID PANEL, STANDARD CHOLESTEROL, TOTAL HDL C

, M.D. 1411 NORTH RADLER DRIVE SUITE 7100 WEST PALM BEACH, FL 33401 Patient EPSTEIN, JEFFREY Exam Date: 1/30/18 Ace No: MRN: 0315192 Dear Dr. Moskowitz, CT NECK Clinical History: 65 y/o male with elevated PTH, concem for parathyroid adenoma. Technique: Multideteotor helical CT scans of the neckw

ith diabetes plus I major ASCVD risk factor, treating to a non-HDL-C goal of <100 mg/dL (LDL-C of <70 mg/c1L) is considered a therapeutic option. HS CRP 1.3 Average relative cardiovascular risk according to MIA/CDC guidelines. For ages >17 hs-CRP mg/L <1.0 1.0-3.0 3.1-10.0 >10.0 Years: Risk

1 ION Requisition: 0006872 Collected: Received: Reported: 11/23/2018 11/27/2018 109:51 EST 11/28/2018 109:22 EST Client #: 78300020 56W5265 MOSKOWITZ, BRUCE W BRUCE MOSKOWITZ, MD Attn: NATIONWIDE ACCOUNT 1411 N FLAGLER DR STE 7100 WEST PALM BEACH, FL 33401-3418 Test Hams In Range Out Of Rang

0006872 Collected: Received: Reported: 11/23/2018 11/27/2018 109:51 EST 11/28/2018 109:22 EST Client #: 78300020 56W5265 MOSKOWITZ, BRUCE W BRUCE MOSKOWITZ, MD Attn: NATIONWIDE ACCOUNT 1411 N FLAGLER DR STE 7100 WEST PALM BEACH, FL 33401-3418 Test Hams In Range Out Of Range PROTEIN, TOTAL AND PROT

with diabetes plus 1 major ASCVD risk factor, treating to a non-HDL-C goal of <100 mg/dL (LDL-C of <70 mg/dL) is considered a therapeutic option. HS CRP 1.1 <5.0 (talc) <130 mg/dL (talc) mg/L The above test was performed; the specimen was lipemic. Average relative cardiovascular risk according

infection or inflammation. Persistent elevation, upon retesting, may be associated with infection and inflammation. Client #: 78300020 56W5265 MOSKOWITZ, BRUCE W BRUCE MOSKOWITZ, MD Attn: NATIONWIDE ACCOUNT 1411 N FLAGLER DR STE 7100 WEST PALM BEACH, FL 33401-3418 Reference Range <200 mg/dL >40

mation. Persistent elevation, upon retesting, may be associated with infection and inflammation. Client #: 78300020 56W5265 MOSKOWITZ, BRUCE W BRUCE MOSKOWITZ, MD Attn: NATIONWIDE ACCOUNT 1411 N FLAGLER DR STE 7100 WEST PALM BEACH, FL 33401-3418 Reference Range <200 mg/dL >40 mg/dL <150 mg/dL mg/dL

with diabetes plus 1 major ASCVD risk factor, treating to a non-HDL-C goal of <100 mg/dL (LDL-C of <70 mg/dL) is considered a therapeutic option. HS CRP 1.3 Average relative cardiovascular risk according to AHA/CDC guidelines. For ages >17 hs-CRP mg/L <1.0 1.0-3.0 3.1-10.0 >10.0 Years: Risk

infection or inflammation. Persistent elevation, upon retesting, may be associated with infection and inflammation. Client #: 78300020 56W5265 MOSKOWITZ, BRUCE W BRUCE MOSKOWITZ, MD Attn: NATIONWIDE ACCOUNT 1411 N FLAGLER DR STE 7100 WEST PALM BEACH, FL 33401.3418 Reference Range <200 mg/dL >40

mation. Persistent elevation, upon retesting, may be associated with infection and inflammation. Client #: 78300020 56W5265 MOSKOWITZ, BRUCE W BRUCE MOSKOWITZ, MD Attn: NATIONWIDE ACCOUNT 1411 N FLAGLER DR STE 7100 WEST PALM BEACH, FL 33401.3418 Reference Range <200 mg/dL >40 mg/dL <150 mg/dL mg/dL

with diabetes plus 1 major ASCVD risk factor, treating to a non-HDL-C goal of <100 mg/dL (LDL-C of <70 mg/dL) is considered a therapeutic option. HS CRP 0.9 Lower relative cardiovascular risk according to AHA/CDC guidelines. For ages >17 hs-CRP mg/L <1.0 1.0-3.0 3.1-10.0 >10.0 Years: Risk A

infection or inflammation. Persistent elevation, upon retesting, may be associated with infection and inflammation. Client #: 78300020 56W5265 MOSKOWITZ, BRUCE W BRUCE MOSKOWITZ, MD Attn: NATIONWIDE ACCOUNT 1411 N FLAGLER DR STE 7100 WEST PALM BEACH, FL 33401-3418 Reference Range 125-200 mg/dL

mation. Persistent elevation, upon retesting, may be associated with infection and inflammation. Client #: 78300020 56W5265 MOSKOWITZ, BRUCE W BRUCE MOSKOWITZ, MD Attn: NATIONWIDE ACCOUNT 1411 N FLAGLER DR STE 7100 WEST PALM BEACH, FL 33401-3418 Reference Range 125-200 mg/dL > OR = 40 mg/dL <150 mg/d

heart disease. CHOL/HDLC RATIO 8.4 H NON HDL CHOLESTEROL 186 H Target for non-HDL cholesterol is 30 mg/dL higher than LDL cholesterol target. HS CRP 0.8 Lower relative cardiovascular risk according to AHA/CDC guidelines. For ages >17 hs-CRP mg/L <1.0 1.0-3.0 3.1-10.0 >10.0 Years: Risk A

69K Requisition: 0006001 Collected: Received: Reported: 08/03/2018 08/07/2018 I 08:58 EDT 08/07/2018 I 08:59 EDT Client #: 78300020 56W5265 MOSKOWITZ, BRUCE W BRUCE MOSKOWITZ, MD Attn: NATIONWIDE ACCOUNT 1411 N FLAGLER DR STE 7100 WEST PALM BEACH, FL 33401-3418 In Range Out Of Range Referenc

06001 Collected: Received: Reported: 08/03/2018 08/07/2018 I 08:58 EDT 08/07/2018 I 08:59 EDT Client #: 78300020 56W5265 MOSKOWITZ, BRUCE W BRUCE MOSKOWITZ, MD Attn: NATIONWIDE ACCOUNT 1411 N FLAGLER DR STE 7100 WEST PALM BEACH, FL 33401-3418 In Range Out Of Range Reference Range 244 H <200 mg/dL

with diabetes plus 1 major ASCVD risk factor, treating to a non-HDL-C goal of <100 mg/dL (LDL-C of <70 mg/dL) is considered a therapeutic option. HS CRP 1.2 mg/dL (talc) <5.0 (talc) <130 mg/dL (talc) mg/L The above test was performed; the specimen was lipemic. Average relative cardiovascular r

infection or inflammation. Persistent elevation, upon retesting, may be associated with infection and inflammation. Client #: 78300020 56W5265 MOSKOWITZ. BRUCE W BRUCE MOSKOWITZ, MD Attn: NATIONWIDE ACCOUNT 1411 N FLAGLER DR STE 7100 WEST PALM BEACH, FL 33401-3418 Reference Range <200 mg/dL >40

mation. Persistent elevation, upon retesting, may be associated with infection and inflammation. Client #: 78300020 56W5265 MOSKOWITZ. BRUCE W BRUCE MOSKOWITZ, MD Attn: NATIONWIDE ACCOUNT 1411 N FLAGLER DR STE 7100 WEST PALM BEACH, FL 33401-3418 Reference Range <200 mg/dL >40 mg/dL <150 mg/dL mg/dL

with diabetes plus 1 major ASCVD risk factor, treating to a non-HDL-C goal of <100 mg/dL (LDL-C of <70 mg/dL) is considered a therapeutic option. HS CRP 1.2 Average relative cardiovascular risk according to AHA/CDC guidelines. For ages >17 hs-CRP mg/L <1.0 1.0-3.0 3.1-10.0 >10.0 Years: Risk

LIN ALBUMIN/GLOBULIN RATIO BILIRUBIN, TOTAL 64 74 NOT APPLICABLE 140 4.7 106 24 10.0 7.0 4.4 2.6 1.7 0.8 Client #: 78300020 56W5265 BRUCE MOSKOWITZ, MD Ann: NATIONWIDE ACCOUNT 1411 N FLAGLER DR STE 7100 WEST PALM BEACH, FL 33401-3418 Reference Range <200 mg/dL >40 mg/dL <150 mg/dL mg/dL (

dL 11.0-15.0 % 140-400 Thousand/uL 7.5-12.5 fL 1500-7800 cells/uL 850-3900 cells/uL 200-950 cells/uL 15-500 cells/uL 0-200 cells/uL Lab MI HS CRP PERFORMING SITE: MI QUEST DIAGNOSTICS.MIAMI. HMO COMMERCE PARKWAY. MIRAMAR. FL 33015.3938 Laboratocc Outdo': JULIE I. FRIEDMAN.MD.CLIA. IOD0277334

1L Requisition: 0000315 Collected: II/25/2016 Received : 11/25/2016 / 20:16 EST Reported: 11/28/2016 / 18:47 EST Client 4: 78300020 56W5265 MOSKOWITZ, BRUCE W BRUCE MOSKOWITZ, MD Attn: NATIONWIDE ACCOUNT 1411 N FLAGLER DR STE 7100 WEST PALM BEACH. FL 33401-3418 Test Name In Range PROTEIN, TO

ease. CHD or with CHOL/HDLC RATIO 4.8 NON HDL CHOLESTEROL 113 Target for non-HDL cholesterol is 30 mg/dL higher than LDL cholesterol target. HS CRP 0.9 Lower relative cardiovascular risk according to Ama/cnc guidelines. FOr ages >17 ha-CRP mg/L <1.0 1.0-3.0 3.1-10.0 >10.0 Years: Risk A

1L Requisition: 0000315 Collected: II/25/2016 Received : 11/25/2016 / 20:16 EST Reported: 11/28/2016 / 18:47 EST Client 4: 78300020 56W5265 MOSKOWITZ, BRUCE W BRUCE MOSKOWITZ, MD Attn: NATIONWIDE ACCOUNT 1411 N FLAGLER DR STE 7100 WEST PALM BEACH. FL 33401-3418 Test Name In Range PROTEIN, TO

ease. CHD or with CHOL/HDLC RATIO 4.8 NON HDL CHOLESTEROL 113 Target for non-HDL cholesterol is 30 mg/dL higher than LDL cholesterol target. HS CRP 0.9 Lower relative cardiovascular risk according to Ama/cnc guidelines. FOr ages >17 ha-CRP mg/L <1.0 1.0-3.0 3.1-10.0 >10.0 Years: Risk A